Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Gene-Deleted Vaccines
Revenue, means the sales value of Gene-Deleted Vaccines
This report studies sales (consumption) of Gene-Deleted Vaccines in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)
Indian Immunologicals Ltd (India)
Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
Protein Sciences Corporation (US)
Virbac SA (France)
Zoetis Inc. (US)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Gene-Deleted Vaccines in these regions, from 2011 to 2021 (forecast), like
USA
China
Europe
Japan
India
Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Gene-Deleted Vaccines in each application, can be divided into
Application 1
Application 2
Application 3
Global Gene-Deleted Vaccines Sales Market Report 2016
1 Gene-Deleted Vaccines Overview
1.1 Product Overview and Scope of Gene-Deleted Vaccines
1.2 Classification of Gene-Deleted Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Gene-Deleted Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Gene-Deleted Vaccines Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Gene-Deleted Vaccines (2011-2021)
1.5.1 Global Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
1.5.2 Global Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
2 Global Gene-Deleted Vaccines Competition by Manufacturers, Type and Application
2.1 Global Gene-Deleted Vaccines Market Competition by Manufacturers
2.1.1 Global Gene-Deleted Vaccines Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Gene-Deleted Vaccines Revenue and Share by Manufacturers (2011-2016)
2.2 Global Gene-Deleted Vaccines (Volume and Value) by Type
2.2.1 Global Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
2.2.2 Global Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Global Gene-Deleted Vaccines (Volume and Value) by Regions
2.3.1 Global Gene-Deleted Vaccines Sales and Market Share by Regions (2011-2016)
2.3.2 Global Gene-Deleted Vaccines Revenue and Market Share by Regions (2011-2016)
2.4 Global Gene-Deleted Vaccines (Volume) by Application
3 USA Gene-Deleted Vaccines (Volume, Value and Sales Price)
3.1 USA Gene-Deleted Vaccines Sales and Value (2011-2016)
3.1.1 USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
3.1.2 USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
3.1.3 USA Gene-Deleted Vaccines Sales Price Trend (2011-2016)
3.2 USA Gene-Deleted Vaccines Sales and Market Share by Manufacturers
3.3 USA Gene-Deleted Vaccines Sales and Market Share by Type
3.4 USA Gene-Deleted Vaccines Sales and Market Share by Application
4 China Gene-Deleted Vaccines (Volume, Value and Sales Price)
4.1 China Gene-Deleted Vaccines Sales and Value (2011-2016)
4.1.1 China Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
4.1.2 China Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
4.1.3 China Gene-Deleted Vaccines Sales Price Trend (2011-2016)
4.2 China Gene-Deleted Vaccines Sales and Market Share by Manufacturers
4.3 China Gene-Deleted Vaccines Sales and Market Share by Type
4.4 China Gene-Deleted Vaccines Sales and Market Share by Application
5 Europe Gene-Deleted Vaccines (Volume, Value and Sales Price)
5.1 Europe Gene-Deleted Vaccines Sales and Value (2011-2016)
5.1.1 Europe Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
5.1.2 Europe Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
5.1.3 Europe Gene-Deleted Vaccines Sales Price Trend (2011-2016)
5.2 Europe Gene-Deleted Vaccines Sales and Market Share by Manufacturers
5.3 Europe Gene-Deleted Vaccines Sales and Market Share by Type
5.4 Europe Gene-Deleted Vaccines Sales and Market Share by Application
6 Japan Gene-Deleted Vaccines (Volume, Value and Sales Price)
6.1 Japan Gene-Deleted Vaccines Sales and Value (2011-2016)
6.1.1 Japan Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
6.1.2 Japan Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
6.1.3 Japan Gene-Deleted Vaccines Sales Price Trend (2011-2016)
6.2 Japan Gene-Deleted Vaccines Sales and Market Share by Manufacturers
6.3 Japan Gene-Deleted Vaccines Sales and Market Share by Type
6.4 Japan Gene-Deleted Vaccines Sales and Market Share by Application
7 India Gene-Deleted Vaccines (Volume, Value and Sales Price)
7.1 India Gene-Deleted Vaccines Sales and Value (2011-2016)
7.1.1 India Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
7.1.2 India Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
7.1.3 India Gene-Deleted Vaccines Sales Price Trend (2011-2016)
7.2 India Gene-Deleted Vaccines Sales and Market Share by Manufacturers
7.3 India Gene-Deleted Vaccines Sales and Market Share by Type
7.4 India Gene-Deleted Vaccines Sales and Market Share by Application
8 Southeast Asia Gene-Deleted Vaccines (Volume, Value and Sales Price)
8.1 Southeast Asia Gene-Deleted Vaccines Sales and Value (2011-2016)
8.1.1 Southeast Asia Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Gene-Deleted Vaccines Sales Price Trend (2011-2016)
8.2 Southeast Asia Gene-Deleted Vaccines Sales and Market Share by Manufacturers
8.3 Southeast Asia Gene-Deleted Vaccines Sales and Market Share by Type
8.4 Southeast Asia Gene-Deleted Vaccines Sales and Market Share by Application
9 Global Gene-Deleted Vaccines Manufacturers Analysis
9.1 Bayer HealthCare AG (Germany)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Gene-Deleted Vaccines Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Biogenesis-Bago (Argentina)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 126 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim GmbH (Germany)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 146 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Ceva Sante Animale (France)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sept Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Heska Corporation (US)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Indian Immunologicals Ltd (India)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Lohmann Animal Health (US)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Merck Animal Health (US)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Merial Ltd. (US)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Protein Sciences Corporation (US)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Virbac SA (France)
9.12 Zoetis Inc. (US)
10 Gene-Deleted Vaccines Maufacturing Cost Analysis
10.1 Gene-Deleted Vaccines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Gene-Deleted Vaccines
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Gene-Deleted Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Gene-Deleted Vaccines Market Forecast (2016-2021)
14.1 Global Gene-Deleted Vaccines Sales, Revenue Forecast (2016-2021)
14.2 Global Gene-Deleted Vaccines Sales Forecast by Regions (2016-2021)
14.3 Global Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
14.4 Global Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Gene-Deleted Vaccines
Table Classification of Gene-Deleted Vaccines
Figure Global Sales Market Share of Gene-Deleted Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Gene-Deleted Vaccines
Figure Global Sales Market Share of Gene-Deleted Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure China Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure India Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Global Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
Figure Global Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Table Global Gene-Deleted Vaccines Sales of Key Manufacturers (2011-2016)
Table Global Gene-Deleted Vaccines Sales Share by Manufacturers (2011-2016)
Figure 2015 Gene-Deleted Vaccines Sales Share by Manufacturers
Figure 2016 Gene-Deleted Vaccines Sales Share by Manufacturers
Table Global Gene-Deleted Vaccines Revenue by Manufacturers (2011-2016)
Table Global Gene-Deleted Vaccines Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Gene-Deleted Vaccines Revenue Share by Manufacturers
Table 2016 Global Gene-Deleted Vaccines Revenue Share by Manufacturers
Table Global Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
Table Global Gene-Deleted Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Figure Global Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
Table Global Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
Table Global Gene-Deleted Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Figure Global Gene-Deleted Vaccines Revenue Growth Rate by Type (2011-2016)
Table Global Gene-Deleted Vaccines Sales and Market Share by Regions (2011-2016)
Table Global Gene-Deleted Vaccines Sales Share by Regions (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Regions (2011-2016)
Figure Global Gene-Deleted Vaccines Sales Growth Rate by Regions (2011-2016)
Table Global Gene-Deleted Vaccines Revenue and Market Share by Regions (2011-2016)
Table Global Gene-Deleted Vaccines Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Regions (2011-2016)
Figure Global Gene-Deleted Vaccines Revenue Growth Rate by Regions (2011-2016)
Table Global Gene-Deleted Vaccines Sales and Market Share by Application (2011-2016)
Table Global Gene-Deleted Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Application (2011-2016)
Figure Global Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table USA Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table USA Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table USA Gene-Deleted Vaccines Sales by Type (2011-2016)
Table USA Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table USA Gene-Deleted Vaccines Sales by Application (2011-2016)
Table USA Gene-Deleted Vaccines Market Share by Application (2011-2016)
Figure China Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure China Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure China Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table China Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table China Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table China Gene-Deleted Vaccines Sales by Type (2011-2016)
Table China Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table China Gene-Deleted Vaccines Sales by Application (2011-2016)
Table China Gene-Deleted Vaccines Market Share by Application (2011-2016)
Figure Europe Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Europe Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Europe Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Europe Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table Europe Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table Europe Gene-Deleted Vaccines Sales by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Sales by Application (2011-2016)
Table Europe Gene-Deleted Vaccines Market Share by Application (2011-2016)
Figure Japan Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Japan Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Japan Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Japan Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table Japan Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table Japan Gene-Deleted Vaccines Sales by Type (2011-2016)
Table Japan Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table Japan Gene-Deleted Vaccines Sales by Application (2011-2016)
Table Japan Gene-Deleted Vaccines Market Share by Application (2011-2016)
Figure India Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure India Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure India Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table India Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table India Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table India Gene-Deleted Vaccines Sales by Type (2011-2016)
Table India Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table India Gene-Deleted Vaccines Sales by Application (2011-2016)
Table India Gene-Deleted Vaccines Market Share by Application (2011-2016)
Figure Southeast Asia Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Southeast Asia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Sales by Manufacturers (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Market Share by Manufacturers (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Sales by Type (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Market Share by Type (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Sales by Application (2011-2016)
Table Southeast Asia Gene-Deleted Vaccines Market Share by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ceva Sante Animale (France) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Heska Corporation (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lohmann Animal Health (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Animal Health (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merial Ltd. (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Protein Sciences Corporation (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Virbac SA (France) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zoetis Inc. (US) Gene-Deleted Vaccines Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene-Deleted Vaccines
Figure Manufacturing Process Analysis of Gene-Deleted Vaccines
Figure Gene-Deleted Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
Table Major Buyers of Gene-Deleted Vaccines
Table Distributors/Traders List
Figure Global Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Global Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Gene-Deleted Vaccines Sales Forecast by Regions (2016-2021)
Table Global Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
Table Global Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...